Sulnox Group PLC

Declaration of Voting Results & Voting Rights Announcements • Sep 28, 2023

National Storage Mechanism | Additional information

RNS Number : 9054N

SulNOx Group PLC

28 September 2023

28 September 2023

SulNOx Group Plc (the "Company" or "SulNOx")

Director's Share Purchase

(Aquis Stock Exchange: SNOX)

The Company is pleased to announce that Lord Nicholas Fairfax, a non-executive director of the Company, has purchased 28,000 ordinary shares of 2 pence each ("Ordinary Shares").  Following the purchase, Lord Fairfax holds 239,757 Ordinary Shares, equivalent to 0.22% of the issued Ordinary Shares.

- Ends -

For further information please contact:

SulNOx Group plc

Steven Cowin, CFO

[email protected]

Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

Tel: 020 3328 5656

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lord Nicholas Fairfax

2

Reason for notification

a)

Position / status

Director - Non-Executive 

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SulNOx Group plc

b)

LEI

21380011EU95E93AQN91

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2 pence each

ISIN: GB00BJVQQP66

Nature of the transaction

Purchase of shares on the market

c)

Price(s) and volumes(s)

Price(s)	Volume(s)
20.44p	28,000

d)

Aggregated information

Aggregated volume

Price

N/A

e)

Date of the transaction

27 September 2023

f)

Place of the transaction

Aquis Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXUBOBROVUKUAR